• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, August 26, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Androgens: Clinical Research and Therapeutics: Launching in 2020

Bioengineer by Bioengineer
May 4, 2020
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: Mary Ann Liebert, Inc., publishers

New Rochelle, NY, May 4, 2020 Androgens: Clinical Research and Therapeutics a new peer-reviewed, open access journal dedicated to testosterone and other androgens, is now accepting submissions for publication in 2020. The Journal aims to publish the highest-quality peer-reviewed articles from all disciplines of medicine, bringing together the numerous areas of testosterone and other androgens clinical research that previously have been dispersed over multiple specialty journals. Androgens is spearheaded by Editor-in-Chief Abdul Traish, PhD, and Senior Editor Abraham Morgentaler, MD, and is the official journal of the Androgen Society. The journal is supported by an international editorial board of world-renowned researchers and will publish under the Creative Commons Attribution 4.0 (CC-BY and CC-BY-NC) licenses to ensure broad dissemination and participation.

“Though we are very much aware of the current COVID-19 global crisis and the urgency the situation requires, we want to share some positive news with our global research community in announcing the launch of this very important journal.” Says Dr. Abdul Traish, Editor-in Chief. “I am committed to working closely with my colleagues serving on the editorial board, authors, and reviewers across the globe to make this journal the most sought-after resource for scientific and clinical information on testosterone deficiency and its therapy,” says Dr. Traish.

Androgens will publish critical research articles, reviews, case reports, and other contributions related to testosterone deficiency and its treatment in diverse patient populations, including transgender patients, and spanning multiple specialties, such as urology, diabetes, metabolism, and endocrinology.

Dr. Abraham Morgentaler, who is President of the Androgen Society says the launch of this journal is a “a major achievement for the Androgen Society, which is dedicated to providing excellence in research, education, and clinical practice regarding testosterone deficiency and its treatment.”

Authors are now be able to submit articles to the Journal for consideration. Submit your research today or choose to learn more about the Journal, read its aims and scope, and find submission guidelines on the Androgens website.

Submit Today

###

About the Publisher

Mary Ann Liebert, Inc., publishers is globally recognized for its authoritative publications. Celebrating its 40th anniversary in 2020, the company is renowned for its prescience in identifying and nurturing critical areas of science and biomedical research. Please visit our website to peruse the publications launched by this privately held company.

Media Contact
Kathryn Ryan
[email protected]

Original Source

https://home.liebertpub.com/news/androgens-clinical-research-and-therapeutics-new-open-access-peer-reviewed-journal-launching-in-2020/3705

Tags: DiabetesDisease in the Developing WorldEndocrinologyMedicine/HealthMetabolism/Metabolic DiseasesSex-Linked Conditions
Share12Tweet8Share2ShareShareShare2

Related Posts

Link Between Immune Inflammation and Diabetic Retinopathy Stages

August 26, 2025

Spatial Cues Drive Multiplexed Theta Coding

August 26, 2025

BU Study Reveals How Type 2 Diabetes Blood Factors Fuel Breast Cancer Aggressiveness

August 26, 2025

Smart Virtual Screening for JAK3 Covalent Inhibitors

August 26, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    147 shares
    Share 59 Tweet 37
  • Molecules in Focus: Capturing the Timeless Dance of Particles

    142 shares
    Share 57 Tweet 36
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    115 shares
    Share 46 Tweet 29
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    81 shares
    Share 32 Tweet 20

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Urban Planning Unequally Burdens Traveller Sites Environmentally

Link Between Immune Inflammation and Diabetic Retinopathy Stages

Unseen Whirlwinds: Researchers Discover ‘Hidden’ Vortices That May Impact Soil and Snow Movement

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.